Health

6 HEALTH • Spring 2015 New England Regional Headache Center offers comprehensive neurological evaluation and treatment of migraine and other headaches by a multi-disciplinary team of dedicated professionals. We also provide nerve blocks, Botox treatment and infusion therapy. Herbert Markley MD Carolyn Benson APRN, BC Shivang Joshi MD, RPh www.nerhc.org For more information or to schedule an appointment contact us at 508.890.5633 85 Prescott St. Suite 101 Worcester, MA 01605 New England Regional Headache Center the two organizations. But stake- holders nationwide will also watch how the project plays out, said Denis Leary, executive director of Veterans Inc., a Worcester-based nonprofit that serves veterans at risk for home- lessness. Leary said medical school chancellor Michael Collins and Col. John Collins, regional director of the VA Central Western Massachusetts Health Care System, have drafted a viable proposal to build a VA treat- ment facility large enough to accom- modate Worcester County's sizeable veteran population. The proposed project would include a new, 100,000-square-foot building would house a research annex and poten- tially replace the VA's Community Based Outpatient Clinic on Lincoln Street. WORCESTER — UMass Memorial Health Care (UMMHC) has posted a $29-million operating surplus for fiscal 2014, according to an audited report the Worcester-based health care system released. The operating surplus represents a turnaround from 2013, when UMMHC reported an operating loss of $55 million for the fiscal year ending Sept. 30, 2013. According to UMMHC, payments increased in fiscal 2014, rising to $2.25 billion, compared with over $2 billion in fiscal 2013. The system's net profit totaled $60.8 million in fiscal 2014, including investment income. That's down from $72.9 million last year, as UMMHC spent $16.4 million on reducing its work- force. FITCHBURG — Micron Products of Fitchburg has signed an exclusive manufacturing agreement for New Era Orthopaedics knee, hip and spine implant systems. Under the five-year agreement, Micron Products will manufacture FDA- approved orthopedic implants, with orders set to begin being filled in the second half of 2015. New Era is based in Pennsylvania and specializ- es in primary joint replacement and spine implants. Micron is a wholly- owned subsidiary of Arrhythmia Research Technology Inc. WORCESTER — Community Healthlink and UMass Memorial Health Care are among 10 organi- zations sharing $1.3 million in grants under a new program admin- istered by the Blue Cross Blue Shield of Massachusetts Foundation. The program, Fostering Effective Integration of Behavioral Health and Primary Care, will support organiza- tions that treat people who have behavioral health problems and other medical issues. The foundation said it looked for organizations with collaborative, co-located and inte- grated service models for patients with a range of medical and behav- ioral health needs, including support for their families. WORCESTER — Generex Biotechnology Corp. of Worcester, a developer of drug delivery technol- ogy, said it has entered into an agreement with Canadian medical marijuana development firm CannScience Innovations Inc. to license its drug delivery system for delivery of medical marijuana prod- ucts. According to a statement, CannScience is developing a product pipeline of proprietary drug, device and delivery technologies. On Nov. 18, CannScience entered into a non- binding letter of intent to lease Generex's proprietary RapidMist drug delivery technologies to be used in oral delivery of its medical marijuana products. MARLBOROUGH — Marlborough- based biotechnology firm RXi Pharmaceuticals said three-month observations have confirmed the effectiveness of its first product can- didate, RXI-109, in the treatment of post-surgical scars. The results show that when RXI-109 is delivered two weeks after scar-revision surgery, evaluators are better able to identify the area of the scar treated with RXI-109. This supports RXi's deci- sion to deliver treatment two weeks after surgery, rather than the acute inflammatory phase of the healing process, according to a statement. MILFORD — Edward J. Kelly, presi- dent of Milford Regional Medical Center, will also become CEO of the health care organization in 2016, Milford Regional announced. Kelly will take over the additional role from Francis M. Saba, who is retir- ing after having served as both presi- { Health Care Briefs } Continued from Page 5

• Cover